Semilux International Ltd. Announces Filing of Annual Report on Form 20-F for December 31, 2023
May 15, 2024 16:45 ET
|
Semilux International Ltd.
Taipei, Taiwan, May 15, 2024 (GLOBE NEWSWIRE) -- Semilux International Ltd. (“Semilux” or the “Company”) (NASDAQ: SELX), today announced that it filed its annual report on Form 20-F (the “Form...
Jeffs’ Brands Files its 2023 Annual Report on Form 20-F
April 01, 2024 09:20 ET
|
Jeffs' Brands Ltd
Tel Aviv, Israel, April 01, 2024 (GLOBE NEWSWIRE) -- Jeffs’ Brands Ltd. (“Jeffs’ Brands” or the “Company”) (Nasdaq: JFBR, JFBRW), a data-driven e-commerce company operating on the Amazon...
CHEERS Telepathy Unveils Year of the Dragon Edition, Elevating AI-Powered Content Marketing to New Heights
February 20, 2024 07:00 ET
|
Cheer Holding, Inc.
BEIJING, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Cheer Holding, Inc. (NASDAQ: CHR) ("Cheer Holding," or the "Company"), a leading provider of advanced mobile internet infrastructure and platform...
Hennessy Capital Investment Corp. VI Announces Postponement of its Special Meeting of Stockholders to 3 P.M. ET on September 29
September 29, 2023 01:07 ET
|
Hennessy Capital Investment Corp. VI
New York, NY, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Hennessy Capital Investment Corp. VI (NASDAQ: HCVI) (the “Company”) today announced that its special meeting of the stockholders (the “Meeting”)...
High Arctic to Announce 2022 Fourth Quarter Results
March 08, 2023 22:28 ET
|
High Arctic Energy Services Inc.
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAW CALGARY,...
BCI ANNOUNCES 7.4 PER CENT ANNUAL RETURN FOR FISCAL 2022
July 21, 2022 09:00 ET
|
BCI - British Columbia Investment Management Corp
Victoria, BC, Canada, July 21, 2022 (GLOBE NEWSWIRE) -- Highlights for fiscal year ending March 31, 2022: One-year annual return of 7.4%, representing $4.4 billion in added value Five-year...
Immunicum AB: Immunicum AB (publ) offentliggör årsredovisning för 2021
April 15, 2022 02:00 ET
|
Immunicum AB
Immunicum AB (“Immunicum” publ; IMMU.ST), ett bioläkemedelsföretag fokuserat på behandlingar mot tumörrecidiv och svårbehandlade etablerade tumörer, meddelar idag att årsredovisningen för 2021 nu...
Immunicum AB: Immunicum AB (publ) Publishes the Annual Report for 2021
April 15, 2022 02:00 ET
|
Immunicum AB
Immunicum AB (“Immunicum” publ; IMMU.ST), a biopharmaceutical company focused on therapies addressing tumor recurrence and hard-to-treat established tumors, today announced that its Annual Report for...
Immunicum AB (publ) offentliggör årsredovisning för 2020
April 12, 2021 02:59 ET
|
Immunicum AB
Pressmeddelande 12 april 2021 Immunicum AB (publ) offentliggör årsredovisning för 2020 Immunicum AB meddelar idag att årsredovisningen för 2020 nu finns tillgänglig på bolagets hemsida,...
Immunicum AB (publ) Publishes the Annual Report for 2020
April 12, 2021 02:59 ET
|
Immunicum AB
Press Release 12 April 2021 Immunicum AB (publ) Publishes the Annual Report for 2020 Immunicum AB (publ; IMMU.ST), today announced that its Annual Report for 2020 is now available on the...